Cargando…
Plasma osteoprotegerin is related to carotid and peripheral arterial disease, but not to myocardial ischemia in type 2 diabetes mellitus
BACKGROUND: Cardiovascular disease (CVD) is frequent in type 2 diabetes mellitus patients due to accelerated atherosclerosis. Plasma osteoprotegerin (OPG) has evolved as a biomarker for CVD. We examined the relationship between plasma OPG levels and different CVD manifestations in type 2 diabetes. M...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3163516/ https://www.ncbi.nlm.nih.gov/pubmed/21838881 http://dx.doi.org/10.1186/1475-2840-10-76 |
_version_ | 1782210951837122560 |
---|---|
author | Poulsen, Mikael K Nybo, Mads Dahl, Jordi Hosbond, Susanne Poulsen, Tina S Johansen, Allan Høilund-Carlsen, Poul F Beck-Nielsen, Henning Rasmussen, Lars M Henriksen, Jan E |
author_facet | Poulsen, Mikael K Nybo, Mads Dahl, Jordi Hosbond, Susanne Poulsen, Tina S Johansen, Allan Høilund-Carlsen, Poul F Beck-Nielsen, Henning Rasmussen, Lars M Henriksen, Jan E |
author_sort | Poulsen, Mikael K |
collection | PubMed |
description | BACKGROUND: Cardiovascular disease (CVD) is frequent in type 2 diabetes mellitus patients due to accelerated atherosclerosis. Plasma osteoprotegerin (OPG) has evolved as a biomarker for CVD. We examined the relationship between plasma OPG levels and different CVD manifestations in type 2 diabetes. METHODS: Type 2 diabetes patients without known CVD referred consecutively to a diabetes clinic for the first time (n = 305, aged: 58.6 ± 11.3 years, diabetes duration: 4.5 ± 5.3 years) were screened for carotid arterial disease, peripheral arterial disease, and myocardial ischemia by means of carotid artery ultrasonography, peripheral ankle and toe systolic blood pressure measurements, and myocardial perfusion scintigraphy (MPS). In addition, plasma OPG concentrations and other CVD-related markers were measured. RESULTS: The prevalence of carotid arterial disease, peripheral arterial disease, and myocardial ischemia was 42%, 15%, and 30%, respectively. Plasma OPG was significantly increased in patients with carotid and peripheral arterial disease compared to patients without (p < 0.001, respectively), however, this was not the case for patients with myocardial ischemia versus those without (p = 0.71). When adjusted for age, HbA1c and U-albumin creatinine ratio in a multivariate logistic regression analysis, plasma OPG remained strongly associated with carotid arterial disease (adjusted OR: 2.12; 95% CI: 1.22-3.67; p = 0.008), but not with peripheral arterial disease or myocardial ischemia. CONCLUSIONS: Increased plasma OPG concentration is associated with carotid and peripheral arterial disease in patients with type 2 diabetes, whereas no relation is observed with respect to myocardial ischemia on MPS. The reason for this discrepancy is unknown. TRIAL REGISTRATION NUMBER: at http://www.clinicaltrial.gov: NCT00298844 |
format | Online Article Text |
id | pubmed-3163516 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-31635162011-08-30 Plasma osteoprotegerin is related to carotid and peripheral arterial disease, but not to myocardial ischemia in type 2 diabetes mellitus Poulsen, Mikael K Nybo, Mads Dahl, Jordi Hosbond, Susanne Poulsen, Tina S Johansen, Allan Høilund-Carlsen, Poul F Beck-Nielsen, Henning Rasmussen, Lars M Henriksen, Jan E Cardiovasc Diabetol Original Investigation BACKGROUND: Cardiovascular disease (CVD) is frequent in type 2 diabetes mellitus patients due to accelerated atherosclerosis. Plasma osteoprotegerin (OPG) has evolved as a biomarker for CVD. We examined the relationship between plasma OPG levels and different CVD manifestations in type 2 diabetes. METHODS: Type 2 diabetes patients without known CVD referred consecutively to a diabetes clinic for the first time (n = 305, aged: 58.6 ± 11.3 years, diabetes duration: 4.5 ± 5.3 years) were screened for carotid arterial disease, peripheral arterial disease, and myocardial ischemia by means of carotid artery ultrasonography, peripheral ankle and toe systolic blood pressure measurements, and myocardial perfusion scintigraphy (MPS). In addition, plasma OPG concentrations and other CVD-related markers were measured. RESULTS: The prevalence of carotid arterial disease, peripheral arterial disease, and myocardial ischemia was 42%, 15%, and 30%, respectively. Plasma OPG was significantly increased in patients with carotid and peripheral arterial disease compared to patients without (p < 0.001, respectively), however, this was not the case for patients with myocardial ischemia versus those without (p = 0.71). When adjusted for age, HbA1c and U-albumin creatinine ratio in a multivariate logistic regression analysis, plasma OPG remained strongly associated with carotid arterial disease (adjusted OR: 2.12; 95% CI: 1.22-3.67; p = 0.008), but not with peripheral arterial disease or myocardial ischemia. CONCLUSIONS: Increased plasma OPG concentration is associated with carotid and peripheral arterial disease in patients with type 2 diabetes, whereas no relation is observed with respect to myocardial ischemia on MPS. The reason for this discrepancy is unknown. TRIAL REGISTRATION NUMBER: at http://www.clinicaltrial.gov: NCT00298844 BioMed Central 2011-08-12 /pmc/articles/PMC3163516/ /pubmed/21838881 http://dx.doi.org/10.1186/1475-2840-10-76 Text en Copyright ©2011 Poulsen et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Investigation Poulsen, Mikael K Nybo, Mads Dahl, Jordi Hosbond, Susanne Poulsen, Tina S Johansen, Allan Høilund-Carlsen, Poul F Beck-Nielsen, Henning Rasmussen, Lars M Henriksen, Jan E Plasma osteoprotegerin is related to carotid and peripheral arterial disease, but not to myocardial ischemia in type 2 diabetes mellitus |
title | Plasma osteoprotegerin is related to carotid and peripheral arterial disease, but not to myocardial ischemia in type 2 diabetes mellitus |
title_full | Plasma osteoprotegerin is related to carotid and peripheral arterial disease, but not to myocardial ischemia in type 2 diabetes mellitus |
title_fullStr | Plasma osteoprotegerin is related to carotid and peripheral arterial disease, but not to myocardial ischemia in type 2 diabetes mellitus |
title_full_unstemmed | Plasma osteoprotegerin is related to carotid and peripheral arterial disease, but not to myocardial ischemia in type 2 diabetes mellitus |
title_short | Plasma osteoprotegerin is related to carotid and peripheral arterial disease, but not to myocardial ischemia in type 2 diabetes mellitus |
title_sort | plasma osteoprotegerin is related to carotid and peripheral arterial disease, but not to myocardial ischemia in type 2 diabetes mellitus |
topic | Original Investigation |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3163516/ https://www.ncbi.nlm.nih.gov/pubmed/21838881 http://dx.doi.org/10.1186/1475-2840-10-76 |
work_keys_str_mv | AT poulsenmikaelk plasmaosteoprotegerinisrelatedtocarotidandperipheralarterialdiseasebutnottomyocardialischemiaintype2diabetesmellitus AT nybomads plasmaosteoprotegerinisrelatedtocarotidandperipheralarterialdiseasebutnottomyocardialischemiaintype2diabetesmellitus AT dahljordi plasmaosteoprotegerinisrelatedtocarotidandperipheralarterialdiseasebutnottomyocardialischemiaintype2diabetesmellitus AT hosbondsusanne plasmaosteoprotegerinisrelatedtocarotidandperipheralarterialdiseasebutnottomyocardialischemiaintype2diabetesmellitus AT poulsentinas plasmaosteoprotegerinisrelatedtocarotidandperipheralarterialdiseasebutnottomyocardialischemiaintype2diabetesmellitus AT johansenallan plasmaosteoprotegerinisrelatedtocarotidandperipheralarterialdiseasebutnottomyocardialischemiaintype2diabetesmellitus AT høilundcarlsenpoulf plasmaosteoprotegerinisrelatedtocarotidandperipheralarterialdiseasebutnottomyocardialischemiaintype2diabetesmellitus AT becknielsenhenning plasmaosteoprotegerinisrelatedtocarotidandperipheralarterialdiseasebutnottomyocardialischemiaintype2diabetesmellitus AT rasmussenlarsm plasmaosteoprotegerinisrelatedtocarotidandperipheralarterialdiseasebutnottomyocardialischemiaintype2diabetesmellitus AT henriksenjane plasmaosteoprotegerinisrelatedtocarotidandperipheralarterialdiseasebutnottomyocardialischemiaintype2diabetesmellitus |